Value Creation with Healthcare Products & Services

The JVCKENWOOD Group develops products for the healthcare industry by making use of the unique expertise that we possess in image and video processing technologies and in optical disk technologies. Seeking to ensure that as many people as possible receive appropriate medical services, we assist those working at the frontlines of medicine by developing medical image display monitors with high diagnostic interpretation efficiency as well as a particle (exosome) measuring instrument that is expected to enable extremely early diagnosis. The healthcare business is also a field that will have a strong impact on the super-aging society, and, as such, we are striving to develop and launch products that meet the needs of medical professionals.


Market Launch of High-Resolution Medical Image Display Monitor

In 2017, JVCKENWOOD launched a new line of 21.3-inch color LCD monitors under its i3 Series, including the CL-S200 2-megapixel color monitor and CL-S300 3-megapixel color monitor. We added the CL-S500 5-megapixel color monitor and CL-S500 monochrome monitor to the line in 2019, and the MS-S300 3-megapixel monochrome monitor and two 5-megapixel dual-monitor models, the CL-S500 Dualstand and MS-S500 Dualstand, in 2020.

 

CL-S500 is a medical image display monitor that achieves both an accurate reproduction of monochrome images and a multi modality diagnostic reading environment that makes use of various medical images in color, including those from ultrasound, endoscope, and pathology tests. In particular, our unique Dynamic Gamma* function automatically distinguishes between monochrome and color images that are intermixed on the screen, in units of pixels. Thus, each image is displayed in the optimal tonal scale in real time. This contributes to improving efficiency in the image interpretation process by enhancing the readability of color images.

* Patent No. 6277984


With enhanced brightness of the LCD panel, MS-S500 and MS-S300 come with 1,000 cd/m2 calibration. In addition, the enhanced contrast ratio has increased the number of perceptual grayscale steps to improve contrast resolution significantly compared with that of conventional models (comparison made by JVCKENWOOD). This has led to improving the visibility of micro-calcifications, tumors and structures, enhancing the sense of depth of the lesioned part in highly dense breast images, and thereby contributing to providing more efficient diagnostic reading.

 

The CL-S500 Dualstand and MS-S500 Dualstand, featuring two 5-megapixel medical imaging monitors in one, allow for synchronized adjustment of the height as well as vertical and horizontal angles of the monitors. A user can adjust both monitors to the most comfortable viewing positions so the brightness, contrast, and color/grayscale are kept optimal. These models also reduce the footprint of the stand base by 46% compared to two conventional models of the same resolution placed side by side, creating a larger workspace by minimizing dead space on the desk.

 

Going Forward, we will continue to promoting widespread use of the i3 Series monitors and strive to provide optimal image interpretation environments for everyone involved in interpreting radiograms.


Mammography/tomosynthesis image display monitors: CL-S500/MS-S500



CL-S500 Dualstand dual-monitor model

Visual comparison based on difference in contrast ratio (image)


ExoCounter that Supports Very Early Diagnosis of Diseases

 

*1 mRNA : mRNA (messenger RNA) is RNA that copies and conveys genetic information on protein synthesis from the DNA sequence.

*2 microRNA : microRNA (miRNA) is one chain of an RNA molecule about the length of 20 nucleotides, and is associated with performing the role of controlling the expression of numerous genes and proteins. In recent years, miRNA found in exosomes has been attracting attention as being effective in the diagnosis of diseases because it remains stable and will not be degraded by enzymes in the blood, and because it changes dramatically in terms of amount and type depending on the type of disease and its level of development.

*3 Nanobead : Nanobeads are beads measured on the scale of nanometers (nm, one-millionth of a millimeter). The nanobeads used in this technology have a diameter of about 200 nm. The surface of the beads is solid-phased with an antibody that docks with substances on the exosomes, which enables the detection of specific exosomes that are being looked for.

 

"ExoCounter" BX-EC3 system components